Jia Li Selected Research

Triple Negative Breast Neoplasms

9/2023	Periostin drives extracellular matrix degradation, stemness, and chemoresistance by activating the MAPK/ERK signaling pathway in triple-negative breast cancer cells.
7/2022	Highly sensitive fluorescent detection of EDIL3 overexpressed exosomes for the diagnosis of triple-negative breast cancer.
1/2022	Chemical degrader enhances the treatment of androgen receptor-positive triple-negative breast cancer.
10/2021	Discovery of Potent and Selective CDK9 Degraders for Targeting Transcription Regulation in Triple-Negative Breast Cancer.
1/2021	Prognostic Biomarkers on a Competitive Endogenous RNA Network Reveals Overall Survival in Triple-Negative Breast Cancer.
1/2021	Long non-coding RNA SNHG8 enhances triple-negative breast cancer cell proliferation and migration by regulating the miR-335-5p/PYGO2 axis.
10/2019	Fluorescence imaging of a potential diagnostic biomarker for breast cancer cells using a peptide-functionalized fluorogenic 2D material.
6/2019	Self-Assembled 2D Glycoclusters for the Targeted Delivery of Theranostic Agents to Triple-Negative Breast Cancer Cells.
1/2019	The Modulatory Properties of Astragalus membranaceus Treatment on Triple-Negative Breast Cancer: An Integrated Pharmacological Method.
4/2018	ZRANB1 Is an EZH2 Deubiquitinase and a Potential Therapeutic Target in Breast Cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jia Li Research Topics

Disease

442	Neoplasms (Cancer) 05/2024 - 10/2002
116	Inflammation (Inflammations) 04/2024 - 05/2007
70	Breast Neoplasms (Breast Cancer) 04/2024 - 05/2005
68	Infections 05/2024 - 08/2006
60	Neoplasm Metastasis (Metastasis) 04/2024 - 06/2009
59	Obesity 04/2024 - 10/2006
53	Fibrosis (Cirrhosis) 04/2024 - 02/2011
51	Type 2 Diabetes Mellitus (MODY) 03/2024 - 10/2005
43	Insulin Resistance 05/2024 - 01/2008
42	Hepatocellular Carcinoma (Hepatoma) 05/2024 - 11/2010
41	Hypoxia (Hypoxemia) 12/2023 - 04/2011
35	Body Weight (Weight, Body) 04/2024 - 05/2007
32	COVID-19 01/2024 - 01/2020
30	Lung Neoplasms (Lung Cancer) 01/2024 - 12/2006
28	Carcinogenesis 03/2024 - 03/2012
28	Pain (Aches) 12/2023 - 07/2008
26	Osteoarthritis 09/2023 - 02/2007
25	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 01/2009
24	Cardiovascular Diseases (Cardiovascular Disease) 09/2023 - 10/2005
22	Hyperglycemia 05/2024 - 01/2010
22	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2009
21	Ischemic Stroke 05/2024 - 06/2006
21	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 10/2002
21	Stroke (Strokes) 02/2024 - 06/2006
21	Ovarian Neoplasms (Ovarian Cancer) 12/2023 - 10/2013
21	Myocardial Infarction 10/2023 - 06/2005
20	Wounds and Injuries (Trauma) 12/2023 - 04/2011
20	Parkinson Disease (Parkinson's Disease) 11/2023 - 01/2009
20	Ischemia 01/2023 - 06/2005
19	Multiple Myeloma 01/2024 - 04/2010
19	Pneumonia (Pneumonitis) 03/2023 - 03/2012
18	Non-alcoholic Fatty Liver Disease 04/2024 - 08/2013
18	Adenocarcinoma of Lung 01/2024 - 12/2013
17	Liver Cirrhosis (Hepatic Cirrhosis) 02/2024 - 12/2011
17	Asthma (Bronchial Asthma) 01/2024 - 03/2012
16	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 09/2009
16	Sepsis (Septicemia) 04/2024 - 01/2014
16	Rheumatoid Arthritis 01/2024 - 02/2007
16	Heart Failure 01/2024 - 09/2006
16	Stomach Neoplasms (Stomach Cancer) 01/2024 - 11/2006
16	Spinal Cord Injuries (Spinal Cord Injury) 10/2023 - 08/2014
16	Alzheimer Disease (Alzheimer's Disease) 10/2023 - 02/2009
15	Necrosis 05/2024 - 08/2012
15	Hypertension (High Blood Pressure) 10/2023 - 06/2006
15	Liver Neoplasms (Liver Cancer) 10/2023 - 12/2015
15	Critical Illness (Critically Ill) 11/2022 - 05/2004
15	Myocardial Ischemia (Ischemic Heart Diseases) 05/2021 - 06/2005
14	Reperfusion Injury 05/2024 - 06/2005
14	Neuroinflammatory Diseases 05/2024 - 10/2012
14	Hemorrhage 05/2024 - 05/2018
14	Atherosclerosis 10/2023 - 11/2004
13	Chronic Hepatitis B 04/2024 - 06/2007
13	Disease Progression 04/2024 - 12/2011
13	Carcinoma (Carcinomatosis) 01/2024 - 01/2010

Drug/Important Bio-Agent (IBA)

152	Proteins (Proteins, Gene)FDA Link 03/2024 - 08/2006
134	Biomarkers (Surrogate Marker)IBA 04/2024 - 05/2009
72	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 01/2006
53	CytokinesIBA 04/2024 - 02/2007
53	MicroRNAs (MicroRNA)IBA 01/2023 - 03/2012
45	Messenger RNA (mRNA)IBA 05/2024 - 10/2008
43	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2016
38	Insulin (Novolin)FDA Link 12/2023 - 01/2006
37	Therapeutic UsesIBA 02/2024 - 07/2008
37	LipidsIBA 02/2024 - 02/2009
35	Long Noncoding RNAIBA 11/2023 - 11/2015
34	EnzymesIBA 06/2023 - 12/2006
33	Interleukin-6 (Interleukin 6)IBA 12/2023 - 01/2014
26	Phosphotransferases (Kinase)IBA 12/2023 - 02/2006
25	Oxygen (Dioxygen)IBA 05/2024 - 05/2005
24	Transcription Factors (Transcription Factor)IBA 05/2024 - 01/2009
24	Antiviral Agents (Antivirals)IBA 04/2024 - 07/2007
24	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 06/2003
23	Small Interfering RNA (siRNA)IBA 04/2024 - 06/2009
22	CateninsIBA 01/2024 - 10/2013
21	Blood Glucose (Blood Sugar)IBA 05/2024 - 01/2008
21	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2019
21	CollagenIBA 02/2024 - 06/2010
21	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2009
20	Indicators and Reagents (Reagents)IBA 01/2024 - 08/2010
18	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 05/2024 - 10/2006
18	Peptides (Polypeptides)IBA 04/2024 - 04/2011
17	Anti-Bacterial Agents (Antibiotics)IBA 04/2024 - 01/2009
16	AlbuminsIBA 01/2024 - 09/2009
16	AntioxidantsIBA 01/2024 - 01/2014
15	LigandsIBA 01/2024 - 07/2006
15	AntigensIBA 01/2024 - 03/2015
15	VaccinesIBA 01/2023 - 01/2010
14	CholesterolIBA 04/2024 - 05/2009
14	Metformin (Glucophage)FDA LinkGeneric 11/2023 - 05/2008
13	SteroidsIBA 04/2024 - 01/2014

Therapy/Procedure

247	Therapeutics 04/2024 - 03/2003
63	Drug Therapy (Chemotherapy) 03/2024 - 11/2006
37	Immunotherapy 03/2024 - 01/2017
23	Electroacupuncture 12/2023 - 01/2012
23	Aftercare (After-Treatment) 10/2023 - 07/2008
15	Precision Medicine 04/2024 - 03/2016
15	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2024 - 11/2006
15	Radiotherapy 12/2023 - 01/2012
13	Oral Administration 05/2024 - 06/2012
13	Length of Stay 01/2024 - 01/2014